METHOD FOR CARRYING OUT EXPERIMENTAL MYOCARDIAL INFARCTION THERAPY

FIELD: medicine. ^ SUBSTANCE: method involves subcutaneously introducing recombinant human granulocytic colony-stimulating factor to an animal at a dose of 100 mcg/kg of body weight once a day during 5 days. ^ EFFECT: enhanced effectiveness in restoring functionally active muscle tissue. ^ 2 dwg, 1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOL'DBERG EVGENIJ DANILOVICH, FOMINA TAT'JANA IVANOVNA, DYGAJ ALEKSANDR MIKHAJLOVICH, STAVROVA LARISA ALEKSANDROVNA, SOTNIKOVA NATAL'JA VLADIMIROVNA, ZHDANOV VADIM VADIMOVICH, MASYCHEVA VALENTINA IVANOVNA, PLOTNIKOV MARK BORISOVICH, ALIEV OLEG IBRAGIMOVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: method involves subcutaneously introducing recombinant human granulocytic colony-stimulating factor to an animal at a dose of 100 mcg/kg of body weight once a day during 5 days. ^ EFFECT: enhanced effectiveness in restoring functionally active muscle tissue. ^ 2 dwg, 1 tbl